Laden…
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Δ-11-Tetrahydrocannabinol acts through the following pharmacological mechanisms:
Designations
IUPAC: Δ-11-Tetrahydrocannabinol
Receptor Profile
Der CB1-Rezeptor ist ein Gi/Go-gekoppelter Cannabinoidrezeptor, der vorwiegend im zentralen Nervensystem exprimiert wird. Er moduliert Neurotransmitterfreisetzung und ist Teil des Endocannabinoidsystems.
Der CB2-Rezeptor ist ein Gi-gekoppelter Cannabinoidrezeptor, der hauptsächlich auf Immunzellen und in geringerem Maße im ZNS exprimiert wird. Er moduliert Entzündungsprozesse und Immunantworten.
Substance Fingerprint
Pharmacological profile based on receptor binding, mechanism of action, and substance class. Limited data — interpret profile with caution.
Synapedia Evidence
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Risks & Harm Reduction — Translation in progress
This section is being translated. Content is available in German.
View in German →The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.